Disclosure of Financial Relationships
As the accredited provider, Des Moines University (DMU) is committed to ensuring that accredited continuing education (1) presents learners with only accurate, balanced, scientifically justified recommendations and (2) protects learners from promotion, marketing, and commercial bias. DMU is responsible for identifying financial relationships between individuals in control of educational content and ineligible companies and managing them to ensure they do not introduce commercial bias.
Financial relationships of any dollar amount are defined as relevant if the educational content is related to the business lines or products of the ineligible company. The Accreditation Council for Continuing Medical Education (ACCME) defines an ineligible company as an organization “whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients." The ACCME does not consider clinical service providers directly to patients as ineligible companies. Ineligible companies are prohibited from engaging in joint providership with accredited providers.
DMU must collect information from all planners, faculty, and others in control of educational content about all their financial relationships with ineligible companies within the prior 24 months. There is no minimum monetary threshold; individuals must disclose all financial relationships with ineligible companies regardless of the amount. Individuals must disclose, irrespective of their view the relevance of the relationship to education. Any individual who refuses to disclose relevant financial relationships will be disqualified from developing, managing, presenting, or evaluating the activity. The disclosure intends not to prevent an individual from being involved in a continuing education activity but to provide learners with information on which to make judgments. This disclosure policy is intended to protect all parties involved from any potential conflict of interest that may arise.
The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Coming soon.
Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relationships have been mitigated by the accredited provider.
- Coming soon.